Last 12 months
Inside the activity.
4 purchase rows · 5 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 1 | 2 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 3 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 22, 2021 Filed Mar 23, 2021 20:31 UTC |
Haytaian Peter DEVP & President, Commercial
|
SaleCommon Stock | 12,416 | $348.52 | $4,327,224.32 |
DisclosureSEC source: 0001156039-21-000038 · wf-form4_161653145347931.xml · nonDerivative · entry 5 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,941 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February, 1, 2021. F4 · price: This transaction was executed in multiple trades at prices ranging from $347.95 to $348.91. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 22, 2021 Filed Mar 23, 2021 20:31 UTC |
Haytaian Peter DEVP & President, Commercial
|
SaleCommon Stock | 9,387 | $347.44 | $3,261,419.28 |
DisclosureSEC source: 0001156039-21-000038 · wf-form4_161653145347931.xml · nonDerivative · entry 4 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,357 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February, 1, 2021. F3 · price: This transaction was executed in multiple trades at prices ranging from $346.93 to $347.91. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 22, 2021 Filed Mar 23, 2021 20:31 UTC |
Haytaian Peter DEVP & President, Commercial
|
SaleCommon Stock | 300 | $345.59 | $103,677.00 |
DisclosureSEC source: 0001156039-21-000038 · wf-form4_161653145347931.xml · nonDerivative · entry 3 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,744 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February, 1, 2021. F2 · price: This transaction was executed in multiple trades at prices ranging from $345.53 to $345.66. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 22, 2021 Filed Mar 23, 2021 20:31 UTC |
Haytaian Peter DEVP & President, Commercial
|
Exercise / conversionCommon Stock | 22,500 | $131.80 | $2,965,500.00 |
DisclosureSEC source: 0001156039-21-000038 · wf-form4_161653145347931.xml · nonDerivative · entry 2 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,044 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 22, 2021 Filed Mar 23, 2021 20:31 UTC |
Haytaian Peter DEVP & President, Commercial
|
Exercise / conversionCommon Stock | 15,593 | $146.93 | $2,291,079.49 |
DisclosureSEC source: 0001156039-21-000038 · wf-form4_161653145347931.xml · nonDerivative · entry 1 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,544 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 05, 2021 Filed Mar 8, 2021 21:31 UTC |
Penczek Ronald WSVP, Chief Accounting Officer
|
SaleCommon Stock | 2,068 | $333.94 | $690,587.92 |
DisclosureSEC source: 0001156039-21-000036 · wf-form4_161523904092853.xml · nonDerivative · entry 1 Penczek Ronald W · CIK 0001659075 · SVP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,137 F1 · price: This transaction was executed in multiple trades at prices ranging from $333.54 to $334.02. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 04, 2021 Filed Mar 5, 2021 21:30 UTC |
Penczek Ronald WSVP, Chief Accounting Officer
|
SaleCommon Stock | 67 | $323.56 | $21,678.52 |
DisclosureSEC source: 0001156039-21-000034 · wf-form4_161497982122760.xml · nonDerivative · entry 1 Penczek Ronald W · CIK 0001659075 · SVP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,205 F1 · price: This transaction was executed in multiple trades at prices ranging from $323.28 to $323.56. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 02, 2021 Filed Mar 3, 2021 21:36 UTC |
BOUDREAUX GAILDirector · President and CEO
|
Tax withholdingCommon Stock | 1,644 | $311.66 | $512,369.04 |
DisclosureSEC source: 0001156039-21-000032 · wf-form4_161480737555662.xml · nonDerivative · entry 4 BOUDREAUX GAIL · CIK 0001287920 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,300 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. F4 · balance_after: Balance includes 78.8 shares acquired on December 22, 2020 through a dividend reinvestment plan. Read SEC document |
| March 02, 2021 Filed Mar 3, 2021 21:35 UTC |
Gallina John EEVP & Chief Financial Officer
|
Tax withholdingCommon Stock | 483 | $311.66 | $150,531.78 |
DisclosureSEC source: 0001156039-21-000030 · wf-form4_161480728684695.xml · nonDerivative · entry 4 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,320 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| March 02, 2021 Filed Mar 3, 2021 21:34 UTC |
Penczek Ronald WSVP, Chief Accounting Officer
|
Tax withholdingCommon Stock | 42 | $311.66 | $13,089.72 |
DisclosureSEC source: 0001156039-21-000029 · wf-form4_161480725900279.xml · nonDerivative · entry 4 Penczek Ronald W · CIK 0001659075 · SVP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,272 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. F4 · balance_after: Balance includes 7.89 shares acquired on December 22, 2020 through a dividend reinvestment plan. Read SEC document |
| March 02, 2021 Filed Mar 3, 2021 21:34 UTC |
MCCARTHY GLORIA MEVP & Chief Administrative Off
|
Tax withholdingCommon Stock | 536 | $311.66 | $167,049.76 |
DisclosureSEC source: 0001156039-21-000028 · wf-form4_161480722114105.xml · nonDerivative · entry 4 MCCARTHY GLORIA M · CIK 0001203671 · EVP & Chief Administrative Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,624 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| March 02, 2021 Filed Mar 3, 2021 21:33 UTC |
Patel Prakash REVP & President, DBG
|
Tax withholdingCommon Stock | 551 | $311.66 | $171,724.66 |
DisclosureSEC source: 0001156039-21-000027 · wf-form4_161480718480807.xml · nonDerivative · entry 4 Patel Prakash R · CIK 0001751045 · EVP & President, DBG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,737 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| March 02, 2021 Filed Mar 3, 2021 21:32 UTC |
STARK LEAHEVP & CHRO
|
Tax withholdingCommon Stock | 715 | $311.66 | $222,836.90 |
DisclosureSEC source: 0001156039-21-000025 · wf-form4_161480711681654.xml · nonDerivative · entry 3 STARK LEAH · CIK 0001679575 · EVP & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,885 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| March 02, 2021 Filed Mar 3, 2021 21:31 UTC |
Norwood Felicia FEVP & President, GBD
|
Tax withholdingCommon Stock | 296 | $311.66 | $92,251.36 |
DisclosureSEC source: 0001156039-21-000024 · wf-form4_161480708330602.xml · nonDerivative · entry 4 Norwood Felicia F · CIK 0001743548 · EVP & President, GBD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,553 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| March 02, 2021 Filed Mar 3, 2021 21:31 UTC |
Haytaian Peter DEVP & President, Commercial
|
Tax withholdingCommon Stock | 492 | $311.66 | $153,336.72 |
DisclosureSEC source: 0001156039-21-000023 · wf-form4_161480704164761.xml · nonDerivative · entry 4 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,951 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:36 UTC |
BOUDREAUX GAILDirector · President and CEO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 43,501 | $0.00 Strike: $311.48 | $0.00 |
DisclosureSEC source: 0001156039-21-000032 · wf-form4_161480737555662.xml · derivative · entry 6 BOUDREAUX GAIL · CIK 0001287920 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,501 Underlying: Common Stock · 43,501 shares Expires 2031-03-01 F5 · derivative.exercise_date: The option represents a right to purchase a total of 43,501 shares, and is exercisable in three annual installments, with two installments of 14,500 shares each and one installment of 14,501 shares, beginning on 3/1/2022, which is the one-year anniversary of the option grant date. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:36 UTC |
BOUDREAUX GAILDirector · President and CEO
|
GrantCommon Stock | 73,240 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-21-000032 · wf-form4_161480737555662.xml · nonDerivative · entry 3 BOUDREAUX GAIL · CIK 0001287920 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,944 F3 · shares: Represents performance based restricted share units. Restrictions lapse on 3/1/2021. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:36 UTC |
BOUDREAUX GAILDirector · President and CEO
|
GrantCommon Stock | 10,595 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-21-000032 · wf-form4_161480737555662.xml · nonDerivative · entry 2 BOUDREAUX GAIL · CIK 0001287920 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,704 F2 · shares: Represents restricted share units. Restrictions lapse as follows: 3,531 shares on 3/1/2022, and 3,532 shares each on 3/1/2023 and 3/1/2024. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:36 UTC |
BOUDREAUX GAILDirector · President and CEO
|
Tax withholdingCommon Stock | 35,564 | $311.48 | $11,077,474.72 |
DisclosureSEC source: 0001156039-21-000032 · wf-form4_161480737555662.xml · nonDerivative · entry 1 BOUDREAUX GAIL · CIK 0001287920 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,109 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:35 UTC |
Gallina John EEVP & Chief Financial Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 12,357 | $0.00 Strike: $311.48 | $0.00 |
DisclosureSEC source: 0001156039-21-000030 · wf-form4_161480728684695.xml · derivative · entry 5 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,357 Underlying: Common Stock · 12,357 shares Expires 2031-03-01 F4 · derivative.exercise_date: The option represents a right to purchase a total of 12,357 shares, and is exercisable in three annual installments of 4,119 shares each, beginning on 3/1/2022, which is the one-year anniversary of the option grant date. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:35 UTC |
Gallina John EEVP & Chief Financial Officer
|
GrantCommon Stock | 23,222 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-21-000030 · wf-form4_161480728684695.xml · nonDerivative · entry 3 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,803 F3 · shares: Represents performance based restricted share units. Restrictions lapse on 3/1/2021. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:35 UTC |
Gallina John EEVP & Chief Financial Officer
|
GrantCommon Stock | 3,010 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-21-000030 · wf-form4_161480728684695.xml · nonDerivative · entry 2 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,581 F2 · shares: Represents restricted share units. Restrictions lapse as follows: 1,003 shares each on 3/1/2022 and 3/1/2023, and 1,004 on 3/1/2024. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:35 UTC |
Gallina John EEVP & Chief Financial Officer
|
Tax withholdingCommon Stock | 10,633 | $311.48 | $3,311,966.84 |
DisclosureSEC source: 0001156039-21-000030 · wf-form4_161480728684695.xml · nonDerivative · entry 1 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,571 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:36 UTC |
Todt Blair WilliamsEVP and Chief Legal Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 8,238 | $0.00 Strike: $311.48 | $0.00 |
DisclosureSEC source: 0001156039-21-000031 · wf-form4_161480733291891.xml · derivative · entry 2 Todt Blair Williams · CIK 0001456430 · EVP and Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,238 Underlying: Common Stock · 8,238 shares Expires 2031-03-01 F2 · derivative.exercise_date: The option represents a right to purchase a total of 8,238 shares, and is exercisable in three annual installments of 2,746 shares each, beginning on 3/1/2022, which is the one-year anniversary of the option grant date. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:36 UTC |
Todt Blair WilliamsEVP and Chief Legal Officer
|
GrantCommon Stock | 2,007 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-21-000031 · wf-form4_161480733291891.xml · nonDerivative · entry 1 Todt Blair Williams · CIK 0001456430 · EVP and Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,804 F1 · shares: Represents restricted share units. Restrictions lapse as follows: 669 shares each on 3/1/2022, 3/1/2023 and 3/1/2024. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:34 UTC |
Penczek Ronald WSVP, Chief Accounting Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 1,315 | $0.00 Strike: $311.48 | $0.00 |
DisclosureSEC source: 0001156039-21-000029 · wf-form4_161480725900279.xml · derivative · entry 5 Penczek Ronald W · CIK 0001659075 · SVP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,315 Underlying: Common Stock · 1,315 shares Expires 2031-03-01 F5 · derivative.exercise_date: The option represents a right to purchase a total of 1,315 shares, and is exercisable in three annual installments, with two installments of 438 shares each and one installment of 439 shares, beginning on 3/1/2022, which is the one-year anniversary of the option grant date. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:34 UTC |
Penczek Ronald WSVP, Chief Accounting Officer
|
GrantCommon Stock | 2,573 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-21-000029 · wf-form4_161480725900279.xml · nonDerivative · entry 3 Penczek Ronald W · CIK 0001659075 · SVP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,314 F3 · shares: Represents performance based restricted share units. Restrictions lapse on 3/1/2021. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:34 UTC |
Penczek Ronald WSVP, Chief Accounting Officer
|
GrantCommon Stock | 322 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-21-000029 · wf-form4_161480725900279.xml · nonDerivative · entry 2 Penczek Ronald W · CIK 0001659075 · SVP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,741 F2 · shares: Represents restricted share units. Restrictions lapse as follows: 107 shares each on 3/1/2022 and 3/1/2023, and 108 shares on 3/1/2024. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:34 UTC |
Penczek Ronald WSVP, Chief Accounting Officer
|
Tax withholdingCommon Stock | 818 | $311.48 | $254,790.64 |
DisclosureSEC source: 0001156039-21-000029 · wf-form4_161480725900279.xml · nonDerivative · entry 1 Penczek Ronald W · CIK 0001659075 · SVP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,419 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:34 UTC |
MCCARTHY GLORIA MEVP & Chief Administrative Off
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 11,533 | $0.00 Strike: $311.48 | $0.00 |
DisclosureSEC source: 0001156039-21-000028 · wf-form4_161480722114105.xml · derivative · entry 5 MCCARTHY GLORIA M · CIK 0001203671 · EVP & Chief Administrative Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,533 Underlying: Common Stock · 11,533 shares Expires 2031-03-01 F4 · derivative.exercise_date: The option represents a right to purchase a total of 11,533 shares, and is exercisable in three annual installments, with two installments of 3,844 shares each and one installment of 3,845 shares, beginning on 3/1/2022, which is the one-year anniversary of the option grant date. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:34 UTC |
MCCARTHY GLORIA MEVP & Chief Administrative Off
|
GrantCommon Stock | 23,222 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-21-000028 · wf-form4_161480722114105.xml · nonDerivative · entry 3 MCCARTHY GLORIA M · CIK 0001203671 · EVP & Chief Administrative Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,160 F3 · shares: Represents performance based restricted share units. Restrictions lapse on 3/1/2021. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:34 UTC |
MCCARTHY GLORIA MEVP & Chief Administrative Off
|
GrantCommon Stock | 2,810 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-21-000028 · wf-form4_161480722114105.xml · nonDerivative · entry 2 MCCARTHY GLORIA M · CIK 0001203671 · EVP & Chief Administrative Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,938 F2 · shares: Represents restricted share units. Restrictions lapse as follows: 936 shares on 3/1/2022, and 937 shares each on 3/1/2023 and 3/1/2024. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:34 UTC |
MCCARTHY GLORIA MEVP & Chief Administrative Off
|
Tax withholdingCommon Stock | 11,971 | $311.48 | $3,728,727.08 |
DisclosureSEC source: 0001156039-21-000028 · wf-form4_161480722114105.xml · nonDerivative · entry 1 MCCARTHY GLORIA M · CIK 0001203671 · EVP & Chief Administrative Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,128 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:33 UTC |
Patel Prakash REVP & President, DBG
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 8,238 | $0.00 Strike: $311.48 | $0.00 |
DisclosureSEC source: 0001156039-21-000027 · wf-form4_161480718480807.xml · derivative · entry 5 Patel Prakash R · CIK 0001751045 · EVP & President, DBG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,238 Underlying: Common Stock · 8,238 shares Expires 2031-03-01 F4 · derivative.exercise_date: The option represents a right to purchase a total of 8,238 shares, and is exercisable in three annual installments of 2,746 shares each, beginning on 3/1/2022, which is the one-year anniversary of the option grant date. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:33 UTC |
Patel Prakash REVP & President, DBG
|
GrantCommon Stock | 7,859 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-21-000027 · wf-form4_161480718480807.xml · nonDerivative · entry 3 Patel Prakash R · CIK 0001751045 · EVP & President, DBG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,288 F3 · shares: Represents performance based restricted share units. Restrictions lapse on 9/4/2021. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:33 UTC |
Patel Prakash REVP & President, DBG
|
GrantCommon Stock | 2,007 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-21-000027 · wf-form4_161480718480807.xml · nonDerivative · entry 2 Patel Prakash R · CIK 0001751045 · EVP & President, DBG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,429 F2 · shares: Represents restricted share units. Restrictions lapse as follows: 669 shares each on 3/1/2022, 3/1/2023 and 3/1/2024. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:33 UTC |
Patel Prakash REVP & President, DBG
|
Tax withholdingCommon Stock | 186 | $311.48 | $57,935.28 |
DisclosureSEC source: 0001156039-21-000027 · wf-form4_161480718480807.xml · nonDerivative · entry 1 Patel Prakash R · CIK 0001751045 · EVP & President, DBG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,422 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:33 UTC |
Alter Jeffrey D.EVP, IngenioRx & Anthem Health
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 10,876 | $0.00 Strike: $311.48 | $0.00 |
DisclosureSEC source: 0001156039-21-000026 · wf-form4_161480714779253.xml · derivative · entry 2 Alter Jeffrey D. · CIK 0001813868 · EVP, IngenioRx & Anthem Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,876 Underlying: Common Stock · 10,876 shares Expires 2031-03-01 F2 · derivative.exercise_date: The option represents a right to purchase a total of 10,876 shares, and is exercisable in three annual installments, with two installments of 3,625 shares each and one installment of 3,626 shares, beginning on 3/1/2022, which is the one-year anniversary of the option grant date. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:33 UTC |
Alter Jeffrey D.EVP, IngenioRx & Anthem Health
|
GrantCommon Stock | 2,649 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-21-000026 · wf-form4_161480714779253.xml · nonDerivative · entry 1 Alter Jeffrey D. · CIK 0001813868 · EVP, IngenioRx & Anthem Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,395 F1 · shares: Represents restricted share units. Restrictions lapse as follows: 883 shares each on 3/1/2022, 3/1/2023 and 3/1/2024. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:32 UTC |
STARK LEAHEVP & CHRO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 7,414 | $0.00 Strike: $311.48 | $0.00 |
DisclosureSEC source: 0001156039-21-000025 · wf-form4_161480711681654.xml · derivative · entry 4 STARK LEAH · CIK 0001679575 · EVP & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,414 Underlying: Common Stock · 7,414 shares Expires 2031-03-01 F3 · derivative.exercise_date: The option represents a right to purchase a total of 7,414 shares, and is exercisable in three annual installments, with two installments of 2,471 shares each and one installment of 2,472 shares, beginning on 3/1/2022, which is the one-year anniversary of the option grant date. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:32 UTC |
STARK LEAHEVP & CHRO
|
GrantCommon Stock | 1,806 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-21-000025 · wf-form4_161480711681654.xml · nonDerivative · entry 2 STARK LEAH · CIK 0001679575 · EVP & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,600 F2 · shares: Represents restricted share units. Restrictions lapse as follows: 602 shares each on 3/1/2022, 3/1/2023 and 3/1/2024. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:32 UTC |
STARK LEAHEVP & CHRO
|
Tax withholdingCommon Stock | 158 | $311.48 | $49,213.84 |
DisclosureSEC source: 0001156039-21-000025 · wf-form4_161480711681654.xml · nonDerivative · entry 1 STARK LEAH · CIK 0001679575 · EVP & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,794 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:31 UTC |
Norwood Felicia FEVP & President, GBD
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 11,533 | $0.00 Strike: $311.48 | $0.00 |
DisclosureSEC source: 0001156039-21-000024 · wf-form4_161480708330602.xml · derivative · entry 5 Norwood Felicia F · CIK 0001743548 · EVP & President, GBD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,533 Underlying: Common Stock · 11,533 shares Expires 2031-03-01 F4 · derivative.exercise_date: The option represents a right to purchase a total of 11,533 shares, and is exercisable in three annual installments, with two installments of 3,844 shares each and one installment of 3,845 shares, beginning on 3/1/2022, which is the one-year anniversary of the option grant date. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:31 UTC |
Norwood Felicia FEVP & President, GBD
|
GrantCommon Stock | 11,831 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-21-000024 · wf-form4_161480708330602.xml · nonDerivative · entry 3 Norwood Felicia F · CIK 0001743548 · EVP & President, GBD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,849 F3 · shares: Represents performance based restricted share units. Restrictions lapse on 7/2/2021 Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:31 UTC |
Norwood Felicia FEVP & President, GBD
|
GrantCommon Stock | 2,810 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-21-000024 · wf-form4_161480708330602.xml · nonDerivative · entry 2 Norwood Felicia F · CIK 0001743548 · EVP & President, GBD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,018 F2 · shares: Represents restricted share units. Restrictions lapse as follows: 936 shares on 3/1/2022, and 937 shares each on 3/1/2023 and 3/1/2024. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:31 UTC |
Norwood Felicia FEVP & President, GBD
|
Tax withholdingCommon Stock | 220 | $311.48 | $68,525.60 |
DisclosureSEC source: 0001156039-21-000024 · wf-form4_161480708330602.xml · nonDerivative · entry 1 Norwood Felicia F · CIK 0001743548 · EVP & President, GBD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,208 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:31 UTC |
Haytaian Peter DEVP & President, Commercial
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 11,533 | $0.00 Strike: $311.48 | $0.00 |
DisclosureSEC source: 0001156039-21-000023 · wf-form4_161480704164761.xml · derivative · entry 5 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,533 Underlying: Common Stock · 11,533 shares Expires 2031-03-01 F4 · derivative.exercise_date: The option represents a right to purchase a total of 11,533 shares, and is exercisable in three annual installments, with two installments of 3,844 shares each and one installment of 3,845 shares, beginning on 3/1/2022, which is the one-year anniversary of the option grant date. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:31 UTC |
Haytaian Peter DEVP & President, Commercial
|
GrantCommon Stock | 23,222 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-21-000023 · wf-form4_161480704164761.xml · nonDerivative · entry 3 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,443 F3 · shares: Represents performance based restricted share units. Restrictions lapse on 3/1/2021. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:31 UTC |
Haytaian Peter DEVP & President, Commercial
|
GrantCommon Stock | 2,810 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-21-000023 · wf-form4_161480704164761.xml · nonDerivative · entry 2 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,221 F2 · shares: Represents restricted share units. Restrictions lapse as follows: 936 shares on 3/1/2022, and 937 shares each on 3/1/2023 and 3/1/2024. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:31 UTC |
Haytaian Peter DEVP & President, Commercial
|
Tax withholdingCommon Stock | 14,231 | $311.48 | $4,432,671.88 |
DisclosureSEC source: 0001156039-21-000023 · wf-form4_161480704164761.xml · nonDerivative · entry 1 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,411 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.